| Name | Title | Contact Details |
|---|
Amicable Healthcare Inc is a Seattle, WA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Franciscan Health System West is a Tacoma, WA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
AliveCor, Inc. is pioneering the creation of FDA-cleared machine learning techniques to enable proactive heart care and is recognized around the world for transforming cardiac care. The FDA-cleared KardiaMobile is the most clinically validated mobile EKG solution on the market. It is recommended by leading cardiologists and used by people worldwide for accurate EKG recordings. KardiaMobile, and KardiaBand, when paired with the Kardia app provide instant analysis for detecting atrial fibrillation (AF) and normal sinus rhythm in an EKG. Kardia is the first A.I. enabled platform to help clinicians manage patients for the early detection of atrial fibrillation, the most common cardiac arrhythmia and one that leads to a five times greater risk of stroke. KardiaBand is the first FDA-cleared medical device accessory for Apple Watch. AliveCor is recognized by FastCompany as 2018`s No. 1 most innovative company in artificial intelligence. AliveCor is a privately-held venture backed company headquartered in Mountain View, Calif.
Elucid is a Boston-based medical technology company using uniquely interpretable and validated AI to provide physicians with a cost-effective means to optimize treatment decisions for patients with cardiovascular disease. Advanced clinical insight from Elucid equips physicians with critical information designed to enable precision medicine. Elucid is the first FDA-Cleared and CE-marked non-invasive software to quantify atherosclerotic plaque characteristics compared to histopathology, including Lipid Rich Necrotic Core. The company has published studies for its derivation of fractional flow reserve (FFRct) based on the vasodilative capacity of the vessel wall and estimation of coding and non-coding RNA transcripts (“Virtual Transcriptomics”). This unique information informs improved treatment decisions by physicians leading to better patient outcomes, improved quality of care, and reduced healthcare costs. The Elucid software is available for commercial use in the U.S. and Europe
A Global Total Solutions Provider Dentsply Sirona is the world`s largest manufacturer of professional dental products and technologies, empowering dental professionals to provide better, safer and faster dental care. Our products and solutions include leading positions and platforms across consumables, equipment, technology, and specialty products. Dentsply Sirona is one global team that brings out the best in our people, lives and breathes high performance and personal accountability, acts with uncompromising integrity, improves the practice of dentistry with an unrelenting commitment to our customers and demonstrates a passion for innovation that shapes the dental industry. As The Dental Solutions Company™, Dentsply Sirona provides dental professionals a comprehensive end-to-end solutions offering. This offering includes some of the best-known and established brands in the industry. We develop, manufacture and market a complete line of dental and oral health products, including general dental supplies and devices, CAD/CAM restoration systems (CEREC and inLab), a full suite of dental restorative products, digital intra-oral, panoramic and 3D imaging systems, dental treatment centers, hand pieces, hygiene systems, and dental specialty products in orthodontics, endodontics and implants. Additionally, our global consumable healthcare product team provides innovative urological and surgical solutions designed to improve quality of life for patients. We are proud to be a preferred partner for dental practices, clinics, dental laboratories and authorized distributors worldwide. Dentsply Sirona`s Global Headquarters is located in York, Pennsylvania, and the International Headquarters is based in Salzburg, Austria. Our shares are listed in the United States on NASDAQ under the symbol XRAY, and in the 12 months ended December 31, 2015, the combined company had pro-forma revenue of approximately $4 billion.